Published in Molecules on July 26, 2013
Physiological consequences of loss of plasminogen activator gene function in mice. Nature (1994) 4.40
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res (2006) 3.17
Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis. Clin Orthop Relat Res (2003) 1.65
Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev (2011) 1.35
The urokinase plasminogen activator system in breast cancer invasion and metastasis. Biomed Pharmacother (2012) 1.21
Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents. J Biol Chem (2004) 1.10
Antitumor and antiviral activity of Colombian medicinal plant extracts. Mem Inst Oswaldo Cruz (1999) 1.01
Antimetastatic activities of Selaginella tamariscina (Beauv.) on lung cancer cells in vitro and in vivo. J Ethnopharmacol (2006) 1.00
Genes associate with abnormal bone cell activity in bone metastasis. Cancer Metastasis Rev (2012) 0.95
Small molecule kinase inhibitors as anti-cancer therapeutics. Mini Rev Med Chem (2012) 0.92
Bioactive crude plant seed extracts from the NCAUR oilseed repository. Phytomedicine (2003) 0.88
The urokinase plasminogen activating system in thyroid cancer: clinical implications. G Chir (2012) 0.86
Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis. J Ethnopharmacol (2011) 0.85
Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-isoquinolinylguanidines. Bioorg Med Chem Lett (2004) 0.85
The urokinase inhibitor p-aminobenzamidine inhibits growth of a human prostate tumor in SCID mice. Int J Cancer (1995) 0.84
Medicinal herbs from the Caribbean National Forest (El Yunque), Puerto Rico. Proc West Pharmacol Soc (2002) 0.81
Suppression of in vitro invasion of human fibrosarcoma cells by a leupeptin analogue inhibiting the urokinase-plasmin system. Biochem Biophys Res Commun (1995) 0.80
u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer. World J Surg Oncol (2012) 0.80
Antiprotease activity of selected Slovak medicinal plants. Pharmazie (2010) 0.79
[Test for urokinase-type plasminogen activator inhibitor of edible plants in vitro]. Zhonghua Yu Fang Yi Xue Za Zhi (2004) 0.78
Extract from Serenoa repens suppresses the invasion activity of human urological cancer cells by inhibiting urokinase-type plasminogen activator. Biol Pharm Bull (2001) 0.78
Cancer treatment with inhibitors of urokinase-type plasminogen activator and plasmin. Expert Opin Investig Drugs (2000) 0.77
Stabilization of alpha-chymotrypsin upon PEGylation correlates with reduced structural dynamics. Biotechnol Bioeng (2008) 1.09
Effect of PEG modification on subtilisin Carlsberg activity, enantioselectivity, and structural dynamics in 1,4-dioxane. Biotechnol Bioeng (2008) 0.95
High initial activity but low storage stability observed for several preparations of subtilisin Carslberg suspended in organic solvents. Biotechnol Prog (2002) 0.87
Synthesis and antiproliferative activity of alkylphosphocholines. Chem Phys Lipids (2003) 0.85
On the activity loss of hydrolases in organic solvents: II. a mechanistic study of subtilisin Carlsberg. BMC Biotechnol (2006) 0.84
Supermacroporous cryogel matrix for integrated protein isolation. Immobilized metal affinity chromatographic purification of urokinase from cell culture broth of a human kidney cell line. J Chromatogr A (2005) 0.82
Integrated bioprocess for the production and isolation of urokinase from animal cell culture using supermacroporous cryogel matrices. Biotechnol Bioeng (2006) 0.82
Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles. J Drug Deliv (2012) 0.82
Effects of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis on HIV-1 reverse transcriptase. Planta Med (2005) 0.81
On the relationship between the activity and structure of PEG-alpha-chymotrypsin conjugates in organic solvents. Biotechnol Bioeng (2006) 0.81
Immobilization of Thermoanaerobium brockii alcohol dehydrogenase on SBA-15. Bioprocess Biosyst Eng (2010) 0.79
A practical selective synthesis of mixed short/long chains glycerophosphocholines. Chem Phys Lipids (2007) 0.78
Effect of prolonged exposure to organic solvents on the active site environment of subtilisin Carlsberg. J Mol Catal B Enzym (2010) 0.78
Monitoring the oxidation of docosahexaenoic acid in lipids. Lipids (2005) 0.77
Enzyme activation in organic solvents: co-lyophilization of subtilisin Carlsberg with methyl-beta-cyclodextrin renders an enzyme catalyst more active than the cross-linked enzyme crystals. Biotechnol Bioeng (2002) 0.77
Para-aminobenzamidine linked regenerated cellulose membranes for plasminogen activator purification: effect of spacer arm length and ligand density. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.77
Role of methoxypolyethylene glycol on the hydration, activity, conformation and dynamic properties of a lipase in a dry film. Biotechnol Bioeng (2008) 0.77
Biguanide-, imine-, and guanidine- based networks as catalysts for transesterification of vegetable oil. React Funct Polym (2010) 0.76
Low operational stability of enzymes in dry organic solvents: changes in the active site might affect catalysis. Molecules (2012) 0.75
Enantioselective Transesterification Catalysis by Nanosized Serine Protease Subtilisin Carlsberg Particles in Tetrahydrofuran. Tetrahedron (2010) 0.75
Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands. Farmaco (2003) 0.75
Enzymatic fingerprints of polysaccharides of Dendrobium officinale and their application in identification of Dendrobium species. J Nat Med (2012) 0.75